 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
July 19, 2014 4:00 PM
|
Abatacept still an option for difficult SLE cases Rheumatology Update It's the first drug targeting co-stimulation between T cells and antigen-presenting cells and, despite its short-comings, it is a possible therapeutic option as an off-label...
|
|
Scooped by
Gilbert C FAURE
July 19, 2014 3:06 AM
|
Plasmonic chip diagnoses diabetes nanotechweb.org T1D is different from T2D in that patients with the disorder have a much higher concentration of autoantibodies against one or more so-called pancreatic islet antigens (such as insulin, glutamic...
|
|
Scooped by
Gilbert C FAURE
July 18, 2014 4:16 AM
|
Genetic Engineering News
Diagnosing Type 1 Diabetes with Nanotechnology
Genetic Engineering News
Type 1 diabetes is an autoimmune disease caused by an inappropriate immune-system attack on healthy tissue.
|
|
Scooped by
Gilbert C FAURE
July 18, 2014 3:34 AM
|
|
|
Scooped by
Gilbert C FAURE
July 17, 2014 3:49 PM
|
Nice explanation of research developments in autoantibody testing, in ppl at risk of developing type 1 #diabetes http://t.co/jhqv1JyuzJ
|
|
Scooped by
Gilbert C FAURE
July 15, 2014 2:20 PM
|
Stanford researchers believe microchip holds key to diabetes diagnoses
Washington Business Journal (blog)
What's the key here? The technical way to find a way to objectively diagnose type 1 from type 2 is to detect an autoantibody in the blood.
|
|
Scooped by
Gilbert C FAURE
July 14, 2014 3:40 PM
|
Molecular mechanisms underlying the prevention of autoimmunity by Roquin ...
|
|
Scooped by
Gilbert C FAURE
July 14, 2014 2:45 PM
|
An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device's inventors at the Stanford University School of Medicine.
|
|
Scooped by
Gilbert C FAURE
July 10, 2014 12:59 PM
|
PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
|
Scooped by
Gilbert C FAURE
July 9, 2014 3:19 PM
|
A recent article in JAMA Neurology features a case report by a team of Mayo Clinic researchers that implies involvement of organs beyond the central nervous system in neuromyelitis optica spectrum disorders.
|
|
Scooped by
Gilbert C FAURE
July 8, 2014 3:05 PM
|
Endocrinology Medical Article: Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes (Human mesenchymal stem cell-derived microvesicles modulate T...
|
|
Scooped by
Gilbert C FAURE
July 8, 2014 2:56 PM
|
Rheumatology Medical Article: Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset (Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and a...
|
|
Scooped by
Gilbert C FAURE
July 4, 2014 3:10 PM
|
MUMBAI,India, July 3, 2014 /PRNewswire/ -- GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases (Glenmark's Novel Monoclonal Antibody GBR 830 for Treatment of Autoimmune Diseases Entering...
|
|
|
Scooped by
Gilbert C FAURE
July 19, 2014 3:56 PM
|
Interdisciplinary Autoimmune Summit Successfully Launches First National ...
|
|
Scooped by
Gilbert C FAURE
July 18, 2014 1:25 PM
|
JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative ...
|
|
Scooped by
Gilbert C FAURE
July 18, 2014 4:15 AM
|
|
|
Scooped by
Gilbert C FAURE
July 17, 2014 4:05 PM
|
Tweet TweetThis week has been very controvesial for the gluten-free food craze that has … (Restaurant Servers: "Your Gluten Allergy Is Fake and I Hate You" Study Immunology Idiot before you rant and Rave!
|
|
Scooped by
Gilbert C FAURE
July 17, 2014 11:10 AM
|
IMI2 1st call for proposals 2014
Cordis News
With regards to Type 1 diabetes, the aims to bring together leading clinicians and researchers from the areas of immunology, beta cell biology, and biomarker research from academia and industry.
|
|
Scooped by
Gilbert C FAURE
July 14, 2014 3:45 PM
|
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes
Nature.com
Type 1 diabetes (T1D) is an autoimmune disease, whereas type 2 diabetes (T2D) results from insulin resistance and beta cell dysfunction.
OBJECTIVE Previous studies demonstrated that the anti-CD3 monoclonal antibody otelixizumab, administered at a total dose of 48–64 mg, can slow the loss of C-peptide in recent-onset type 1 diabetes patients, with frequent ...
|
|
Scooped by
Gilbert C FAURE
July 11, 2014 3:27 PM
|
Treatment (biotherapy excluded) of psoriatic arthritis: an appraisal of methodological quality of international ... http://t.co/xLC85MzJPT
|
|
Scooped by
Gilbert C FAURE
July 9, 2014 3:23 PM
|
|
|
Scooped by
Gilbert C FAURE
July 9, 2014 2:43 PM
|
|
|
Scooped by
Gilbert C FAURE
July 8, 2014 2:57 PM
|
|
|
Scooped by
Gilbert C FAURE
July 8, 2014 4:08 AM
|
|
Scoop.it!
